Loading clinical trials...

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00728364

Anderson-Fabry Disease in Chronic Kidney Disease Patients Not on Renal Replacement Therapy

Anderson-Fabry disease is a rare X-linked lysosomal storage disorder due to the deficiency of alfa-galactosidase A (AGAL). The subsequent accumulation of glycosphingolipids may lead to to cardiac, ren...

Lead sponsor: Klinikum Wels-Grieskirchen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment4,353

Start dateOct 2008

Last updatedApr 12, 2012

Locations shown

Klinikum Wels-Grieskirchen

Wels, Upper Austria

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 12, 2012Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions